Solvents & VOCs — industrial solvent

Dimethylformamide (DMF) in the bedroom

If your bedroom has a faux-leather headboard, an upholstered "PU leather" bed frame, or a synthetic-leather mattress or pillow cover, there is a solvent worth knowing about: N,N-dimethylformamide, or DMF. It is the workhorse solvent used to make polyurethane-coated "vegan leather," it lingers in the finished material as a measurable residue, it is absorbed through skin, and in 2018 it became an IARC Group 2A probable carcinogen. The reassuring part: it washes out, and airing helps.

Dimethylformamide (DMF) — Embr Bedroom Chemistry Atlas

At a glance

Chemical familyA high-production-volume industrial solvent (an amide); the primary solvent used to make synthetic "PU leather"
CAS number68-12-2
Carcinogen statusIARC Group 2A — probably carcinogenic to humans (since 2018; upgraded from Group 3). Limited human evidence (testicular cancer), sufficient animal evidence
Other key hazardsA documented liver toxin; a strong skin penetrant — NIOSH/OSHA limits carry a "skin" notation; reproductive effects reported
Where you encounter itSynthetic "PU leather" / "vegan leather": faux-leather headboards, upholstered bed frames and benches, some mattress and pillow covers, plus shoes, bags and children's play mats
Sleep micro-environment relevanceA residue in PU-coated bedroom materials that can be absorbed through prolonged skin contact and off-gases from new items — reducible by washing and airing
Activated carbon capturePartly relevant for the airborne fraction from new items; the larger lever is washing removable covers and choosing water-based or non-PU materials

Regulatory & certification status

Where Dimethylformamide (DMF) stands across the major regulatory systems and the certifications a bedroom product might carry. Each row links to the governing instrument; where a jurisdiction has no specific measure, that is stated plainly rather than left blank.

European UnionREACH Substance of Very High Concern, on the Candidate List as toxic for reproduction (Art. 57c). Restricted under Annex XVII entry 76 (Commission Regulation (EU) 2021/2030): from 12 December 2023, DMF shall not be placed on the market as a substance on its own or in mixtures at a concentration of 0.3% or more unless manufacturers, importers and downstream users have documented Derived No-Effect Levels (DNELs) for workers of 6 mg/m3 (inhalation) and 1.1 mg/kg/day (dermal) and apply risk-management measures keeping exposure below them. It was recommended by ECHA for inclusion in the Authorisation List (Annex XIV) in the 5th recommendation (Feb 2014) but was ultimately addressed by this restriction rather than being added to Annex XIV. Under CLP Annex VI it carries a harmonised classification (index 616-001-00-X) of reproductive toxicant Cat. 1B (H360D, may damage the unborn child) and Acute Tox. 4 (H312/H332). Regulatory — EUR-Lex · ECHA
United StatesUnder California Proposition 65, N,N-dimethylformamide is listed as causing cancer (carcinogenicity endpoint), effective 27 October 2017, via the Labor Code / IARC listing mechanism. It is not listed under Proposition 65 for developmental or reproductive toxicity. (Note: it was considered but declined for listing by the Carcinogen Identification Committee in November 2008 before the later Labor Code listing.) No federal TSCA risk evaluation of DMF has been confirmed: DMF was not among the High-Priority Substances designated in the 18 December 2024 TSCA notice (which named vinyl chloride, acetaldehyde, acrylonitrile, benzenamine/aniline, and MBOCA), nor among the next five chemicals then entering prioritization. Regulatory — OEHHA
CanadaDMF was assessed under CEPA on the Second Priority Substances List (PSL2). Environment Canada and Health Canada concluded it is NOT 'toxic' as defined in section 64 of CEPA 1999, so it was not added to Schedule 1; further options to reduce exposure were not judged a priority at the time. This is a legacy (now archived) PSL assessment rather than a current re-evaluation. Regulatory — Government of Canada
AustraliaAustralia's legacy NICNAS (now AICIS) published a Human Health Tier II IMAP assessment of Formamide, N,N-dimethyl- (DMF) dated 22 March 2013, which identified a reproductive/developmental toxicity concern and noted the IARC carcinogenicity classification of the time (Group 3). No IChEMS/AICIS scheduling restriction on DMF was identified. Regulatory — AICIS
United KingdomFollowing EU exit, Great Britain retained EU harmonised CLP classifications as the starting point for GB Mandatory Classification & Labelling, so DMF's status as a reproductive toxicant Cat. 1B (H360D) carries over under GB CLP. The EU REACH Annex XVII restriction (entry 76) entered into force before the transition cut-off; the cited HSE Northern Ireland notice confirms the restriction applies in Northern Ireland under the Windsor Framework, but the cited sources do not by themselves establish the precise status of the entry-76 restriction under GB (assimilated) REACH, which should be verified against HSE GB guidance before asserting it. Regulatory — HSE Northern Ireland · HSE
InternationalIARC classifies N,N-dimethylformamide in Group 2A (probably carcinogenic to humans), evaluated in Monographs Volume 115 (published 2018) — an upgrade from the earlier Group 3 (not classifiable) evaluation in Volume 71 (1999). No global treaty (Stockholm POPs / Minamata) applies to DMF. Regulatory — IARC
CertificationsCertiPUR / CertiPUR-US (flexible polyurethane foam): the published technical paper does not name dimethylformamide as a prohibited substance. However, its criteria exclude raw materials classified as Carcinogen/Mutagen/Reprotoxic (CMR) Cat. 1A/1B (H340/H350/H360) from intentional use, and DMF's harmonised Repr. 1B (H360D) classification falls within that category-based exclusion. OEKO-TEX Standard 100: DMF (and its analogue DMAc) is monitored as a regulated solvent residue for textiles, subject to a limit value. GREENGUARD / GREENGUARD Gold is a low-VOC emissions certification assessed against a defined chemical list and does not certify specifically against DMF content. Industry — CertiPUR / EUROPUR · OEKO-TEX
The 72-hour test windowPartially captured. DMF is a polar aprotic solvent but only semi-volatile (boiling point ~153 C, vapour pressure ~3.8 hPa at 20 C, slow evaporation rate), so while a chamber test can detect it as a VOC, its low volatility means residual DMF in foam or fibre off-gasses slowly and a short ~72 h emissions test tends to under-capture it relative to longer-term or content-based testing. Inferred — from the compound's volatility/emission profile versus the VOC focus of short chamber tests

What it is

N,N-Dimethylformamide is one of the most widely used industrial solvents in the world, valued because it dissolves a huge range of polymers while evaporating slowly. Its standout consumer application is making synthetic "PU leather" — the polyurethane-coated fabric sold as "vegan leather" or "faux leather." DMF dissolves the polyurethane so it can be spread onto a backing fabric; as the coating cures, most of the solvent is driven off, but a fraction stays behind in the finished material.

For years DMF was treated mainly as an occupational concern, because synthetic-leather factory workers carry the heaviest exposures and show liver effects. Peer-reviewed — Kim et al. 2011, review of DMF in synthetic-leather production Two facts pull it into the consumer realm. First, in 2018 the International Agency for Research on Cancer reclassified DMF as Group 2A, probably carcinogenic to humans — there is limited human evidence (a positive association with testicular cancer) and sufficient animal evidence — an upgrade from its earlier Group 3 status. Regulatory — IARC Monographs Vol. 115, DMF evaluation Second, DMF is absorbed efficiently through intact skin — which is exactly the route a faux-leather surface in contact with your body invokes.

How it relates to the bedroom

The route: residue in "PU leather," absorbed through skin

The bedroom has quietly filled with synthetic leather — faux-leather headboards, upholstered bed frames and storage benches, and some mattress and pillow covers. The key consumer finding is that residual DMF can be measured in polyurethane-based products: in one survey, toddler shoes held about 38 ppm, children's bags 119 ppm, and children's play mats nearly 400 ppm of residual DMF. Peer-reviewed — Park et al. 2017 A headboard or PU-coated cover is the bedroom equivalent of those items — and the play-mat result is a direct parallel for a child's sleep surface.

What makes skin contact the route that matters is DMF's penetration. In synthetic-leather workers with similar airborne exposure but more skin contact, dermal uptake produced a significantly higher body burden that accumulated across the work week — DMF goes through skin readily, not just into the lungs. Peer-reviewed — Chang et al. 2005 That is why its occupational exposure limits carry a "skin" notation. Regulatory — NIOSH Pocket Guide lists DMF with a [skin] designation, flagging dermal absorption as a significant route A faux-leather headboard your head and shoulders rest against, or a PU cover against bare skin all night, is a more plausible exposure path than the air alone.

Keeping it in proportion

This is a residue question, not an acute hazard. The DMF concentrations measured in finished consumer goods are orders of magnitude below the factory-air exposures that drive the liver-toxicity and cancer findings, and most products in the survey met the internationally used 1,000 ppm benchmark. Peer-reviewed — Park et al. 2017 The point is not alarm but awareness: a Group 2A solvent that absorbs through skin is worth reducing where you sleep, especially because reducing it is easy.

What the research says

  • IARC Group 2A since 2018. Limited human evidence (testicular cancer), sufficient animal evidence; upgraded from Group 3. Regulatory — IARC Vol. 115
  • Measurable residue in PU products. Up to ~400 ppm in children's play mats; most products under the 1,000 ppm benchmark. Peer-reviewed — Park et al. 2017
  • Absorbed through skin. Dermal uptake drives body burden and accumulates over days. Peer-reviewed — Chang et al. 2005
  • Liver is the main toxicity target. Well documented in synthetic-leather workers. Peer-reviewed — Kim et al. 2011

What helps reduce it

Wash removable PU-coated covers before first use. A single wash cut residual DMF in consumer products by 63–85% in the survey — the most effective single step. Peer-reviewed — Park et al. 2017

Air out new faux-leather items. As a solvent residue, DMF dissipates with ventilation and time; let a new headboard or PU bed frame off-gas in a ventilated space before heavy use. Inferred — standard handling for solvent residues in new products

Limit prolonged bare-skin contact while it off-gasses. A pillowcase or cover over a faux-leather surface puts a barrier on the dermal route. Inferred — follows from DMF's skin-absorption route

Choose the material out of the problem. Water-based polyurethane, or genuine/natural materials, avoid the DMF residue at the source. Inferred — water-based PU processing does not use DMF as the solvent

What does NOT help

  • Assuming "vegan" or "eco" leather is solvent-free. Most conventional PU leather is solvent-processed; the marketing term says nothing about residual DMF. Inferred
  • Air filtration alone for a skin-contact source. A carbon filter captures the airborne fraction but does nothing about the residue your skin touches; washing and barriers address that. Inferred

Open research questions

  • Real-world dermal DMF uptake from faux-leather furniture and covers in the home, as opposed to factory settings. Speculation
  • How quickly residual DMF in a new PU-leather headboard or cover declines under normal household conditions. Speculation
  • Whether infant and child sleep surfaces (PU-coated mats and covers) warrant tighter residual-DMF limits than current benchmarks. Speculation

The Embr Exposure Ledger: Dimethylformamide (DMF)

One chemical, several public questions, answered from independent datasets and joined here — the environment it shows up in, the body burden it carries, how it is regulated, and what actually reduces it.

This compound appears in 5 of the Embr Exposure Ledger’s 10 exposure datasets.
At what level would it matter?
Published benchmarks exist: an inhalation reference concentration of 0.03 mg/m³ (EPA IRIS) and a residential indoor-air screening level of 31 µg/m³, set on a non-cancer endpoint (hazard quotient of 1). A screening level is the concentration at which EPA would look further, not a boundary between safe and harmful. The ledger holds no measured sleeping-environment concentration for this compound, so there is nothing here to compare the benchmark against — it tells you what would matter, not what is in any room.Source: US EPA, Regional Screening Levels (RSL) Summary Table — consolidated toxicity values from IRIS, PPRTV, ATSDR, Cal EPA and OPP
Who releases it?
129 US facilities reported releasing it in 2024 across 35 states and territories; 26 Canadian facilities have reported it (2001-2024). These are self-reported quantities leaving a facility, not levels anyone encountered, and the two national programs are not added together — they use different reporting thresholds.Source: US EPA, Toxics Release Inventory (TRI) Basic Data File, 2024 reporting year; Environment and Climate Change Canada, National Pollutant Release Inventory (NPRI), releases 1993-present
Does the law flag it?
Listed under California Proposition 65 for cancer since 2017. On the EU REACH Candidate List as a substance of very high concern for toxic for reproduction since 19-Dec-2012. That is a formal identification, not a ban: it triggers supply-chain disclosure above 0.1% by weight. Carries an EU-wide binding classification as toxic for reproduction (category 1B). That classifies the substance itself; it does not restrict any product.Source: California OEHHA Proposition 65 List (Safe Drinking Water and Toxic Enforcement Act of 1986)Source: ECHA Candidate ListSource: EU CLP Annex VI
Has a regulator acted?
Regulators have acted on products over this compound: 20 EU safety alerts. 3 involved bedding, furniture or textiles. These are actions against specific products, not a measure of the substance in general — and counts follow enforcement attention as much as they follow prevalence.Source: EU Safety Gate (RAPEX), European Commission rapid alert system for dangerous non-food products

Detection and body-burden figures are occurrence data, not a personal measurement or a health diagnosis. Part of the Embr Exposure Ledger — an open, cross-dataset chemical join (download the data), reusable with attribution.

Citations

  1. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 115 (2018). N,N-Dimethylformamide — Evaluation. International Agency for Research on Cancer. Limited human evidence (testicular cancer), sufficient animal evidence; classified Group 2A (probably carcinogenic to humans). NCBI Bookshelf NBK506735 Regulatory
  2. Park Y-G, et al. (2017). A Survey and Studies on the Residual Content of Dimethylformamide and its Reduction in Polyurethane-Based Consumer Products. J. Korean Soc. Qual. Manag. Residual DMF: toddler shoes 38 ppm, children's bags 119 ppm, play mats 396 ppm, safety gloves 826 ppm; a single wash reduced content 63–85%. Via Consensus. DOI 10.7469/jksqm.2017.45.4.769 Peer-reviewed
  3. Chang H-Y, et al. (2005). Total body burden arising from a week's repeated dermal exposure to N,N-dimethylformamide. Occup. Environ. Med. Dermal exposure drove higher DMF body burden, accumulating across a five-day cycle. Via Consensus. DOI 10.1136/oem.2004.016089 Peer-reviewed
  4. Kim TH, et al. (2011). Clinical Outcomes of Occupational Exposure to N,N-Dimethylformamide: Perspectives from Experimental Toxicology. Saf. Health Work. Review of DMF as a synthetic-leather solvent and its liver toxicity. Via Consensus. DOI 10.5491/shaw.2011.2.2.97 Peer-reviewed
  5. NIOSH Pocket Guide to Chemical Hazards — Dimethylformamide (CAS 68-12-2). U.S. CDC/NIOSH. Lists a [skin] notation, identifying dermal absorption as a significant exposure route; liver/kidney target organs. cdc.gov/niosh Regulatory

Frequently asked questions

  • What is dimethylformamide (DMF)?

    N,N-Dimethylformamide (DMF) is a high-production-volume industrial solvent. Its single biggest consumer-relevant use is making synthetic "PU leather" — the polyurethane-coated fabric used for faux-leather headboards, upholstered furniture, some mattress and pillow covers, bags, shoes and children's play mats. DMF dissolves the polyurethane during manufacturing, and some of it stays behind in the finished material as a residue.

  • Is DMF a carcinogen?

    Yes, probably. In 2018 the International Agency for Research on Cancer reclassified DMF as Group 2A, probably carcinogenic to humans, based on limited evidence in humans (a positive association with testicular cancer) and sufficient evidence in experimental animals. This was an upgrade from its previous Group 3 ("not classifiable") status. DMF is also a well-documented liver toxin and a strong skin penetrant — it is absorbed through intact skin, so the NIOSH and OSHA limits carry a "skin" notation.

  • Why does it matter in the bedroom?

    Because synthetic "PU leather" is everywhere in modern bedrooms — faux-leather headboards, upholstered bed frames and benches, some mattress and pillow covers — and residual DMF has been measured in polyurethane-based consumer products, including children's play mats at nearly 400 ppm. DMF is absorbed through the skin, so a faux-leather headboard or a PU-coated cover in prolonged skin contact is a more plausible exposure route than air alone. The amounts in finished goods are far below occupational levels, so this is a low-level residue question, not an acute hazard.

  • What reduces DMF exposure?

    Two things help. First, washing: a single wash cut residual DMF in consumer products by 63–85% in one study, so laundering removable PU-coated covers before first use is worthwhile. Second, ventilation and time: as a solvent residue, DMF dissipates from new products with airing. Choosing water-based polyurethane or genuine materials over solvent-processed "PU leather" avoids the residue at the source, and keeping a new faux-leather item out of prolonged bare-skin contact while it is off-gassing is sensible.

Related compounds


Embr is a sleep environment company researching and addressing the chemistry of the bedroom. Research and product development in progress. This page is informational and is not medical advice.

Last reviewed 2026-06-27. If you find a factual error, contact us.